Judith Klimovsky V - 30 Oct 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship: Director
Issuer ticker: TECH
Reported as of: 30 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Nov 2025, 17:23:45 UTC
Prior SEC filing: 28 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ Andrew Nick as Attorney-in-Fact for Judith V. Klimovsky pursuant to Power of Attorney filed previously.

Key filing fact

Judith Klimovsky V filed Form 4 for BIO-TECHNE Corp (TECH) on 03 Nov 2025.

Key facts

This page summarizes Judith Klimovsky V's Form 4 filing for BIO-TECHNE Corp (TECH).
2 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 03 Nov 2025, 17:23.

Change

Previous filing in this sequence was filed on 28 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001762247 Primary reporting owner

Klimovsky Judith V.

Relationship: Director
Address: 614 MCKINLEY PLACE NE, MINNEAPOLIS
Signature: /s/ Andrew Nick as Attorney-in-Fact for Judith V. Klimovsky pursuant to Power of Attorney filed previously.
Signature date: 03 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Award

Transaction value: $0
Shares: +1,640
Change %: +77%
Price: $0.000000
Shares after: 3,782
Date: 30 Oct 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +3,777
Change %
Price: $0.000000
Shares after: 3,777
Date: 30 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,777
Exercise price: $60.96
Footnotes: F1

TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,610
Date: 30 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,610
Exercise price: $73.46

TECH holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,511
Date: 30 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,511
Exercise price: $68.37

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.